AstraZeneca PLC (AZN)

AstraZeneca Revenue

AstraZeneca had revenue of $15.29B in the quarter ending March 31, 2026, with 12.51% growth. This brings the company's revenue in the last twelve months to $60.44B, up 9.93% year-over-year. In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth.

• Revenue (ttm): $60.44B
• Revenue Growth: +9.93%
• P/S Ratio: 4.67
• Revenue / Employee: $635,531
• Employees: 95,100
• Market Cap: 282.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	58.74B	4.67B	8.63%
Dec 31, 2024	54.07B	8.26B	18.03%
Dec 31, 2023	45.81B	1.46B	3.29%
Dec 31, 2022	44.35B	6.93B	18.53%
Dec 31, 2021	37.42B	10.80B	40.58%
Dec 31, 2020	26.62B	2.23B	9.16%
Dec 31, 2019	24.38B	2.29B	10.38%
Dec 31, 2018	22.09B	-375.00M	-1.67%
Dec 31, 2017	22.47B	-537.00M	-2.33%
Dec 31, 2016	23.00B	-1.71B	-6.90%
Dec 31, 2015	24.71B	-1.84B	-6.93%
Dec 31, 2014	26.55B	741.00M	2.87%
Dec 31, 2013	25.81B	-2.17B	-7.75%
Dec 31, 2012	27.97B	-5.62B	-16.72%
Dec 31, 2011	33.59B	322.00M	0.97%
Dec 31, 2010	33.27B	465.00M	1.42%
Dec 31, 2009	32.80B	1.20B	3.81%
Dec 31, 2008	31.60B	2.04B	6.91%
Dec 31, 2007	29.56B	3.08B	11.65%
Dec 31, 2006	26.48B	2.53B	10.54%
Dec 31, 2005	23.95B	-	-

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error